Global CMO and CDMO biotechnology Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “CMO and CDMO biotechnology Industry Forecast” looks at past sales and reviews total world CMO and CDMO biotechnology sales in 2022, providing a comprehensive analysis by region and market sector of projected CMO and CDMO biotechnology sales for 2023 through 2029. With CMO and CDMO biotechnology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CMO and CDMO biotechnology industry.
This Insight Report provides a comprehensive analysis of the global CMO and CDMO biotechnology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CMO and CDMO biotechnology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CMO and CDMO biotechnology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CMO and CDMO biotechnology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CMO and CDMO biotechnology.
The global CMO and CDMO biotechnology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for CMO and CDMO biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for CMO and CDMO biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for CMO and CDMO biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key CMO and CDMO biotechnology players cover Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics and AbbVie, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of CMO and CDMO biotechnology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “CMO and CDMO biotechnology Industry Forecast” looks at past sales and reviews total world CMO and CDMO biotechnology sales in 2022, providing a comprehensive analysis by region and market sector of projected CMO and CDMO biotechnology sales for 2023 through 2029. With CMO and CDMO biotechnology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CMO and CDMO biotechnology industry.
This Insight Report provides a comprehensive analysis of the global CMO and CDMO biotechnology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on CMO and CDMO biotechnology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CMO and CDMO biotechnology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CMO and CDMO biotechnology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CMO and CDMO biotechnology.
The global CMO and CDMO biotechnology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for CMO and CDMO biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for CMO and CDMO biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for CMO and CDMO biotechnology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key CMO and CDMO biotechnology players cover Patheon, Catalent, Samsung Biologics, Lonza., Boehringer Ingelheim, Samsung BioLogics, AGC Biologics, WuXi Biologics and AbbVie, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of CMO and CDMO biotechnology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Service
- Product
- Platform/ Expression System
- Large Enterprise
- SME
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Patheon
- Catalent
- Samsung Biologics
- Lonza.
- Boehringer Ingelheim
- Samsung BioLogics
- AGC Biologics
- WuXi Biologics
- AbbVie
- Avid Bioservices
- Fujifilm Diosynth Biotechnologies
- KBI Biopharma (JSR Corporation)
- Cytovance Biologics
- Xpress Biologic
- Rentschler Biopharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CMO and CDMO biotechnology Market Size 2018-2029
2.1.2 CMO and CDMO biotechnology Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 CMO and CDMO biotechnology Segment by Type
2.2.1 Service
2.2.2 Product
2.2.3 Platform/ Expression System
2.3 CMO and CDMO biotechnology Market Size by Type
2.3.1 CMO and CDMO biotechnology Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
2.4 CMO and CDMO biotechnology Segment by Application
2.4.1 Large Enterprise
2.4.2 SME
2.5 CMO and CDMO biotechnology Market Size by Application
2.5.1 CMO and CDMO biotechnology Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
3 CMO AND CDMO BIOTECHNOLOGY MARKET SIZE BY PLAYER
3.1 CMO and CDMO biotechnology Market Size Market Share by Players
3.1.1 Global CMO and CDMO biotechnology Revenue by Players (2018-2023)
3.1.2 Global CMO and CDMO biotechnology Revenue Market Share by Players (2018-2023)
3.2 Global CMO and CDMO biotechnology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CMO AND CDMO BIOTECHNOLOGY BY REGIONS
4.1 CMO and CDMO biotechnology Market Size by Regions (2018-2023)
4.2 Americas CMO and CDMO biotechnology Market Size Growth (2018-2023)
4.3 APAC CMO and CDMO biotechnology Market Size Growth (2018-2023)
4.4 Europe CMO and CDMO biotechnology Market Size Growth (2018-2023)
4.5 Middle East & Africa CMO and CDMO biotechnology Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas CMO and CDMO biotechnology Market Size by Country (2018-2023)
5.2 Americas CMO and CDMO biotechnology Market Size by Type (2018-2023)
5.3 Americas CMO and CDMO biotechnology Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CMO and CDMO biotechnology Market Size by Region (2018-2023)
6.2 APAC CMO and CDMO biotechnology Market Size by Type (2018-2023)
6.3 APAC CMO and CDMO biotechnology Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CMO and CDMO biotechnology by Country (2018-2023)
7.2 Europe CMO and CDMO biotechnology Market Size by Type (2018-2023)
7.3 Europe CMO and CDMO biotechnology Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CMO and CDMO biotechnology by Region (2018-2023)
8.2 Middle East & Africa CMO and CDMO biotechnology Market Size by Type (2018-2023)
8.3 Middle East & Africa CMO and CDMO biotechnology Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CMO AND CDMO BIOTECHNOLOGY MARKET FORECAST
10.1 Global CMO and CDMO biotechnology Forecast by Regions (2024-2029)
10.1.1 Global CMO and CDMO biotechnology Forecast by Regions (2024-2029)
10.1.2 Americas CMO and CDMO biotechnology Forecast
10.1.3 APAC CMO and CDMO biotechnology Forecast
10.1.4 Europe CMO and CDMO biotechnology Forecast
10.1.5 Middle East & Africa CMO and CDMO biotechnology Forecast
10.2 Americas CMO and CDMO biotechnology Forecast by Country (2024-2029)
10.2.1 United States CMO and CDMO biotechnology Market Forecast
10.2.2 Canada CMO and CDMO biotechnology Market Forecast
10.2.3 Mexico CMO and CDMO biotechnology Market Forecast
10.2.4 Brazil CMO and CDMO biotechnology Market Forecast
10.3 APAC CMO and CDMO biotechnology Forecast by Region (2024-2029)
10.3.1 China CMO and CDMO biotechnology Market Forecast
10.3.2 Japan CMO and CDMO biotechnology Market Forecast
10.3.3 Korea CMO and CDMO biotechnology Market Forecast
10.3.4 Southeast Asia CMO and CDMO biotechnology Market Forecast
10.3.5 India CMO and CDMO biotechnology Market Forecast
10.3.6 Australia CMO and CDMO biotechnology Market Forecast
10.4 Europe CMO and CDMO biotechnology Forecast by Country (2024-2029)
10.4.1 Germany CMO and CDMO biotechnology Market Forecast
10.4.2 France CMO and CDMO biotechnology Market Forecast
10.4.3 UK CMO and CDMO biotechnology Market Forecast
10.4.4 Italy CMO and CDMO biotechnology Market Forecast
10.4.5 Russia CMO and CDMO biotechnology Market Forecast
10.5 Middle East & Africa CMO and CDMO biotechnology Forecast by Region (2024-2029)
10.5.1 Egypt CMO and CDMO biotechnology Market Forecast
10.5.2 South Africa CMO and CDMO biotechnology Market Forecast
10.5.3 Israel CMO and CDMO biotechnology Market Forecast
10.5.4 Turkey CMO and CDMO biotechnology Market Forecast
10.5.5 GCC Countries CMO and CDMO biotechnology Market Forecast
10.6 Global CMO and CDMO biotechnology Forecast by Type (2024-2029)
10.7 Global CMO and CDMO biotechnology Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Patheon
11.1.1 Patheon Company Information
11.1.2 Patheon CMO and CDMO biotechnology Product Offered
11.1.3 Patheon CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Patheon Main Business Overview
11.1.5 Patheon Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent CMO and CDMO biotechnology Product Offered
11.2.3 Catalent CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics CMO and CDMO biotechnology Product Offered
11.3.3 Samsung Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 Lonza.
11.4.1 Lonza. Company Information
11.4.2 Lonza. CMO and CDMO biotechnology Product Offered
11.4.3 Lonza. CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Lonza. Main Business Overview
11.4.5 Lonza. Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim CMO and CDMO biotechnology Product Offered
11.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Samsung BioLogics
11.6.1 Samsung BioLogics Company Information
11.6.2 Samsung BioLogics CMO and CDMO biotechnology Product Offered
11.6.3 Samsung BioLogics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Samsung BioLogics Main Business Overview
11.6.5 Samsung BioLogics Latest Developments
11.7 AGC Biologics
11.7.1 AGC Biologics Company Information
11.7.2 AGC Biologics CMO and CDMO biotechnology Product Offered
11.7.3 AGC Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 AGC Biologics Main Business Overview
11.7.5 AGC Biologics Latest Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Information
11.8.2 WuXi Biologics CMO and CDMO biotechnology Product Offered
11.8.3 WuXi Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 WuXi Biologics Main Business Overview
11.8.5 WuXi Biologics Latest Developments
11.9 AbbVie
11.9.1 AbbVie Company Information
11.9.2 AbbVie CMO and CDMO biotechnology Product Offered
11.9.3 AbbVie CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 AbbVie Main Business Overview
11.9.5 AbbVie Latest Developments
11.10 Avid Bioservices
11.10.1 Avid Bioservices Company Information
11.10.2 Avid Bioservices CMO and CDMO biotechnology Product Offered
11.10.3 Avid Bioservices CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Avid Bioservices Main Business Overview
11.10.5 Avid Bioservices Latest Developments
11.11 Fujifilm Diosynth Biotechnologies
11.11.1 Fujifilm Diosynth Biotechnologies Company Information
11.11.2 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product Offered
11.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Fujifilm Diosynth Biotechnologies Main Business Overview
11.11.5 Fujifilm Diosynth Biotechnologies Latest Developments
11.12 KBI Biopharma (JSR Corporation)
11.12.1 KBI Biopharma (JSR Corporation) Company Information
11.12.2 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product Offered
11.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 KBI Biopharma (JSR Corporation) Main Business Overview
11.12.5 KBI Biopharma (JSR Corporation) Latest Developments
11.13 Cytovance Biologics
11.13.1 Cytovance Biologics Company Information
11.13.2 Cytovance Biologics CMO and CDMO biotechnology Product Offered
11.13.3 Cytovance Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Cytovance Biologics Main Business Overview
11.13.5 Cytovance Biologics Latest Developments
11.14 Xpress Biologic
11.14.1 Xpress Biologic Company Information
11.14.2 Xpress Biologic CMO and CDMO biotechnology Product Offered
11.14.3 Xpress Biologic CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Xpress Biologic Main Business Overview
11.14.5 Xpress Biologic Latest Developments
11.15 Rentschler Biopharma
11.15.1 Rentschler Biopharma Company Information
11.15.2 Rentschler Biopharma CMO and CDMO biotechnology Product Offered
11.15.3 Rentschler Biopharma CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Rentschler Biopharma Main Business Overview
11.15.5 Rentschler Biopharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CMO and CDMO biotechnology Market Size 2018-2029
2.1.2 CMO and CDMO biotechnology Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 CMO and CDMO biotechnology Segment by Type
2.2.1 Service
2.2.2 Product
2.2.3 Platform/ Expression System
2.3 CMO and CDMO biotechnology Market Size by Type
2.3.1 CMO and CDMO biotechnology Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
2.4 CMO and CDMO biotechnology Segment by Application
2.4.1 Large Enterprise
2.4.2 SME
2.5 CMO and CDMO biotechnology Market Size by Application
2.5.1 CMO and CDMO biotechnology Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
3 CMO AND CDMO BIOTECHNOLOGY MARKET SIZE BY PLAYER
3.1 CMO and CDMO biotechnology Market Size Market Share by Players
3.1.1 Global CMO and CDMO biotechnology Revenue by Players (2018-2023)
3.1.2 Global CMO and CDMO biotechnology Revenue Market Share by Players (2018-2023)
3.2 Global CMO and CDMO biotechnology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CMO AND CDMO BIOTECHNOLOGY BY REGIONS
4.1 CMO and CDMO biotechnology Market Size by Regions (2018-2023)
4.2 Americas CMO and CDMO biotechnology Market Size Growth (2018-2023)
4.3 APAC CMO and CDMO biotechnology Market Size Growth (2018-2023)
4.4 Europe CMO and CDMO biotechnology Market Size Growth (2018-2023)
4.5 Middle East & Africa CMO and CDMO biotechnology Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas CMO and CDMO biotechnology Market Size by Country (2018-2023)
5.2 Americas CMO and CDMO biotechnology Market Size by Type (2018-2023)
5.3 Americas CMO and CDMO biotechnology Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CMO and CDMO biotechnology Market Size by Region (2018-2023)
6.2 APAC CMO and CDMO biotechnology Market Size by Type (2018-2023)
6.3 APAC CMO and CDMO biotechnology Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CMO and CDMO biotechnology by Country (2018-2023)
7.2 Europe CMO and CDMO biotechnology Market Size by Type (2018-2023)
7.3 Europe CMO and CDMO biotechnology Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CMO and CDMO biotechnology by Region (2018-2023)
8.2 Middle East & Africa CMO and CDMO biotechnology Market Size by Type (2018-2023)
8.3 Middle East & Africa CMO and CDMO biotechnology Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CMO AND CDMO BIOTECHNOLOGY MARKET FORECAST
10.1 Global CMO and CDMO biotechnology Forecast by Regions (2024-2029)
10.1.1 Global CMO and CDMO biotechnology Forecast by Regions (2024-2029)
10.1.2 Americas CMO and CDMO biotechnology Forecast
10.1.3 APAC CMO and CDMO biotechnology Forecast
10.1.4 Europe CMO and CDMO biotechnology Forecast
10.1.5 Middle East & Africa CMO and CDMO biotechnology Forecast
10.2 Americas CMO and CDMO biotechnology Forecast by Country (2024-2029)
10.2.1 United States CMO and CDMO biotechnology Market Forecast
10.2.2 Canada CMO and CDMO biotechnology Market Forecast
10.2.3 Mexico CMO and CDMO biotechnology Market Forecast
10.2.4 Brazil CMO and CDMO biotechnology Market Forecast
10.3 APAC CMO and CDMO biotechnology Forecast by Region (2024-2029)
10.3.1 China CMO and CDMO biotechnology Market Forecast
10.3.2 Japan CMO and CDMO biotechnology Market Forecast
10.3.3 Korea CMO and CDMO biotechnology Market Forecast
10.3.4 Southeast Asia CMO and CDMO biotechnology Market Forecast
10.3.5 India CMO and CDMO biotechnology Market Forecast
10.3.6 Australia CMO and CDMO biotechnology Market Forecast
10.4 Europe CMO and CDMO biotechnology Forecast by Country (2024-2029)
10.4.1 Germany CMO and CDMO biotechnology Market Forecast
10.4.2 France CMO and CDMO biotechnology Market Forecast
10.4.3 UK CMO and CDMO biotechnology Market Forecast
10.4.4 Italy CMO and CDMO biotechnology Market Forecast
10.4.5 Russia CMO and CDMO biotechnology Market Forecast
10.5 Middle East & Africa CMO and CDMO biotechnology Forecast by Region (2024-2029)
10.5.1 Egypt CMO and CDMO biotechnology Market Forecast
10.5.2 South Africa CMO and CDMO biotechnology Market Forecast
10.5.3 Israel CMO and CDMO biotechnology Market Forecast
10.5.4 Turkey CMO and CDMO biotechnology Market Forecast
10.5.5 GCC Countries CMO and CDMO biotechnology Market Forecast
10.6 Global CMO and CDMO biotechnology Forecast by Type (2024-2029)
10.7 Global CMO and CDMO biotechnology Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Patheon
11.1.1 Patheon Company Information
11.1.2 Patheon CMO and CDMO biotechnology Product Offered
11.1.3 Patheon CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Patheon Main Business Overview
11.1.5 Patheon Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent CMO and CDMO biotechnology Product Offered
11.2.3 Catalent CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics CMO and CDMO biotechnology Product Offered
11.3.3 Samsung Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 Lonza.
11.4.1 Lonza. Company Information
11.4.2 Lonza. CMO and CDMO biotechnology Product Offered
11.4.3 Lonza. CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Lonza. Main Business Overview
11.4.5 Lonza. Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim CMO and CDMO biotechnology Product Offered
11.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Samsung BioLogics
11.6.1 Samsung BioLogics Company Information
11.6.2 Samsung BioLogics CMO and CDMO biotechnology Product Offered
11.6.3 Samsung BioLogics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Samsung BioLogics Main Business Overview
11.6.5 Samsung BioLogics Latest Developments
11.7 AGC Biologics
11.7.1 AGC Biologics Company Information
11.7.2 AGC Biologics CMO and CDMO biotechnology Product Offered
11.7.3 AGC Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 AGC Biologics Main Business Overview
11.7.5 AGC Biologics Latest Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Information
11.8.2 WuXi Biologics CMO and CDMO biotechnology Product Offered
11.8.3 WuXi Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 WuXi Biologics Main Business Overview
11.8.5 WuXi Biologics Latest Developments
11.9 AbbVie
11.9.1 AbbVie Company Information
11.9.2 AbbVie CMO and CDMO biotechnology Product Offered
11.9.3 AbbVie CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 AbbVie Main Business Overview
11.9.5 AbbVie Latest Developments
11.10 Avid Bioservices
11.10.1 Avid Bioservices Company Information
11.10.2 Avid Bioservices CMO and CDMO biotechnology Product Offered
11.10.3 Avid Bioservices CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Avid Bioservices Main Business Overview
11.10.5 Avid Bioservices Latest Developments
11.11 Fujifilm Diosynth Biotechnologies
11.11.1 Fujifilm Diosynth Biotechnologies Company Information
11.11.2 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product Offered
11.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Fujifilm Diosynth Biotechnologies Main Business Overview
11.11.5 Fujifilm Diosynth Biotechnologies Latest Developments
11.12 KBI Biopharma (JSR Corporation)
11.12.1 KBI Biopharma (JSR Corporation) Company Information
11.12.2 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product Offered
11.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 KBI Biopharma (JSR Corporation) Main Business Overview
11.12.5 KBI Biopharma (JSR Corporation) Latest Developments
11.13 Cytovance Biologics
11.13.1 Cytovance Biologics Company Information
11.13.2 Cytovance Biologics CMO and CDMO biotechnology Product Offered
11.13.3 Cytovance Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Cytovance Biologics Main Business Overview
11.13.5 Cytovance Biologics Latest Developments
11.14 Xpress Biologic
11.14.1 Xpress Biologic Company Information
11.14.2 Xpress Biologic CMO and CDMO biotechnology Product Offered
11.14.3 Xpress Biologic CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Xpress Biologic Main Business Overview
11.14.5 Xpress Biologic Latest Developments
11.15 Rentschler Biopharma
11.15.1 Rentschler Biopharma Company Information
11.15.2 Rentschler Biopharma CMO and CDMO biotechnology Product Offered
11.15.3 Rentschler Biopharma CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Rentschler Biopharma Main Business Overview
11.15.5 Rentschler Biopharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CMO and CDMO biotechnology Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Service
Table 3. Major Players of Product
Table 4. Major Players of Platform/ Expression System
Table 5. CMO and CDMO biotechnology Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 8. CMO and CDMO biotechnology Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 11. Global CMO and CDMO biotechnology Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global CMO and CDMO biotechnology Revenue Market Share by Player (2018-2023)
Table 13. CMO and CDMO biotechnology Key Players Head office and Products Offered
Table 14. CMO and CDMO biotechnology Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CMO and CDMO biotechnology Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global CMO and CDMO biotechnology Market Size Market Share by Regions (2018-2023)
Table 19. Global CMO and CDMO biotechnology Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global CMO and CDMO biotechnology Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas CMO and CDMO biotechnology Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas CMO and CDMO biotechnology Market Size Market Share by Country (2018-2023)
Table 23. Americas CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 25. Americas CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 27. APAC CMO and CDMO biotechnology Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC CMO and CDMO biotechnology Market Size Market Share by Region (2018-2023)
Table 29. APAC CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 31. APAC CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 33. Europe CMO and CDMO biotechnology Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe CMO and CDMO biotechnology Market Size Market Share by Country (2018-2023)
Table 35. Europe CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 37. Europe CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa CMO and CDMO biotechnology Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of CMO and CDMO biotechnology
Table 46. Key Market Challenges & Risks of CMO and CDMO biotechnology
Table 47. Key Industry Trends of CMO and CDMO biotechnology
Table 48. Global CMO and CDMO biotechnology Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global CMO and CDMO biotechnology Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global CMO and CDMO biotechnology Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global CMO and CDMO biotechnology Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Patheon Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 53. Patheon CMO and CDMO biotechnology Product Offered
Table 54. Patheon CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Patheon Main Business
Table 56. Patheon Latest Developments
Table 57. Catalent Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 58. Catalent CMO and CDMO biotechnology Product Offered
Table 59. Catalent Main Business
Table 60. Catalent CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Catalent Latest Developments
Table 62. Samsung Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 63. Samsung Biologics CMO and CDMO biotechnology Product Offered
Table 64. Samsung Biologics Main Business
Table 65. Samsung Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Samsung Biologics Latest Developments
Table 67. Lonza. Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 68. Lonza. CMO and CDMO biotechnology Product Offered
Table 69. Lonza. Main Business
Table 70. Lonza. CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Lonza. Latest Developments
Table 72. Boehringer Ingelheim Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 73. Boehringer Ingelheim CMO and CDMO biotechnology Product Offered
Table 74. Boehringer Ingelheim Main Business
Table 75. Boehringer Ingelheim CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Boehringer Ingelheim Latest Developments
Table 77. Samsung BioLogics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 78. Samsung BioLogics CMO and CDMO biotechnology Product Offered
Table 79. Samsung BioLogics Main Business
Table 80. Samsung BioLogics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Samsung BioLogics Latest Developments
Table 82. AGC Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 83. AGC Biologics CMO and CDMO biotechnology Product Offered
Table 84. AGC Biologics Main Business
Table 85. AGC Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. AGC Biologics Latest Developments
Table 87. WuXi Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 88. WuXi Biologics CMO and CDMO biotechnology Product Offered
Table 89. WuXi Biologics Main Business
Table 90. WuXi Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. WuXi Biologics Latest Developments
Table 92. AbbVie Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 93. AbbVie CMO and CDMO biotechnology Product Offered
Table 94. AbbVie Main Business
Table 95. AbbVie CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. AbbVie Latest Developments
Table 97. Avid Bioservices Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 98. Avid Bioservices CMO and CDMO biotechnology Product Offered
Table 99. Avid Bioservices Main Business
Table 100. Avid Bioservices CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Avid Bioservices Latest Developments
Table 102. Fujifilm Diosynth Biotechnologies Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 103. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product Offered
Table 104. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Fujifilm Diosynth Biotechnologies Main Business
Table 106. Fujifilm Diosynth Biotechnologies Latest Developments
Table 107. KBI Biopharma (JSR Corporation) Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 108. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product Offered
Table 109. KBI Biopharma (JSR Corporation) Main Business
Table 110. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. KBI Biopharma (JSR Corporation) Latest Developments
Table 112. Cytovance Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 113. Cytovance Biologics CMO and CDMO biotechnology Product Offered
Table 114. Cytovance Biologics Main Business
Table 115. Cytovance Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Cytovance Biologics Latest Developments
Table 117. Xpress Biologic Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 118. Xpress Biologic CMO and CDMO biotechnology Product Offered
Table 119. Xpress Biologic Main Business
Table 120. Xpress Biologic CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Xpress Biologic Latest Developments
Table 122. Rentschler Biopharma Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 123. Rentschler Biopharma CMO and CDMO biotechnology Product Offered
Table 124. Rentschler Biopharma Main Business
Table 125. Rentschler Biopharma CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Rentschler Biopharma Latest Developments
Table 1. CMO and CDMO biotechnology Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Service
Table 3. Major Players of Product
Table 4. Major Players of Platform/ Expression System
Table 5. CMO and CDMO biotechnology Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 8. CMO and CDMO biotechnology Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 11. Global CMO and CDMO biotechnology Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global CMO and CDMO biotechnology Revenue Market Share by Player (2018-2023)
Table 13. CMO and CDMO biotechnology Key Players Head office and Products Offered
Table 14. CMO and CDMO biotechnology Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CMO and CDMO biotechnology Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global CMO and CDMO biotechnology Market Size Market Share by Regions (2018-2023)
Table 19. Global CMO and CDMO biotechnology Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global CMO and CDMO biotechnology Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas CMO and CDMO biotechnology Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas CMO and CDMO biotechnology Market Size Market Share by Country (2018-2023)
Table 23. Americas CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 25. Americas CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 27. APAC CMO and CDMO biotechnology Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC CMO and CDMO biotechnology Market Size Market Share by Region (2018-2023)
Table 29. APAC CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 31. APAC CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 33. Europe CMO and CDMO biotechnology Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe CMO and CDMO biotechnology Market Size Market Share by Country (2018-2023)
Table 35. Europe CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 37. Europe CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa CMO and CDMO biotechnology Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa CMO and CDMO biotechnology Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa CMO and CDMO biotechnology Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of CMO and CDMO biotechnology
Table 46. Key Market Challenges & Risks of CMO and CDMO biotechnology
Table 47. Key Industry Trends of CMO and CDMO biotechnology
Table 48. Global CMO and CDMO biotechnology Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global CMO and CDMO biotechnology Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global CMO and CDMO biotechnology Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global CMO and CDMO biotechnology Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Patheon Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 53. Patheon CMO and CDMO biotechnology Product Offered
Table 54. Patheon CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Patheon Main Business
Table 56. Patheon Latest Developments
Table 57. Catalent Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 58. Catalent CMO and CDMO biotechnology Product Offered
Table 59. Catalent Main Business
Table 60. Catalent CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Catalent Latest Developments
Table 62. Samsung Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 63. Samsung Biologics CMO and CDMO biotechnology Product Offered
Table 64. Samsung Biologics Main Business
Table 65. Samsung Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Samsung Biologics Latest Developments
Table 67. Lonza. Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 68. Lonza. CMO and CDMO biotechnology Product Offered
Table 69. Lonza. Main Business
Table 70. Lonza. CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Lonza. Latest Developments
Table 72. Boehringer Ingelheim Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 73. Boehringer Ingelheim CMO and CDMO biotechnology Product Offered
Table 74. Boehringer Ingelheim Main Business
Table 75. Boehringer Ingelheim CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Boehringer Ingelheim Latest Developments
Table 77. Samsung BioLogics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 78. Samsung BioLogics CMO and CDMO biotechnology Product Offered
Table 79. Samsung BioLogics Main Business
Table 80. Samsung BioLogics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Samsung BioLogics Latest Developments
Table 82. AGC Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 83. AGC Biologics CMO and CDMO biotechnology Product Offered
Table 84. AGC Biologics Main Business
Table 85. AGC Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. AGC Biologics Latest Developments
Table 87. WuXi Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 88. WuXi Biologics CMO and CDMO biotechnology Product Offered
Table 89. WuXi Biologics Main Business
Table 90. WuXi Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. WuXi Biologics Latest Developments
Table 92. AbbVie Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 93. AbbVie CMO and CDMO biotechnology Product Offered
Table 94. AbbVie Main Business
Table 95. AbbVie CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. AbbVie Latest Developments
Table 97. Avid Bioservices Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 98. Avid Bioservices CMO and CDMO biotechnology Product Offered
Table 99. Avid Bioservices Main Business
Table 100. Avid Bioservices CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Avid Bioservices Latest Developments
Table 102. Fujifilm Diosynth Biotechnologies Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 103. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product Offered
Table 104. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Fujifilm Diosynth Biotechnologies Main Business
Table 106. Fujifilm Diosynth Biotechnologies Latest Developments
Table 107. KBI Biopharma (JSR Corporation) Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 108. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product Offered
Table 109. KBI Biopharma (JSR Corporation) Main Business
Table 110. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. KBI Biopharma (JSR Corporation) Latest Developments
Table 112. Cytovance Biologics Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 113. Cytovance Biologics CMO and CDMO biotechnology Product Offered
Table 114. Cytovance Biologics Main Business
Table 115. Cytovance Biologics CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Cytovance Biologics Latest Developments
Table 117. Xpress Biologic Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 118. Xpress Biologic CMO and CDMO biotechnology Product Offered
Table 119. Xpress Biologic Main Business
Table 120. Xpress Biologic CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Xpress Biologic Latest Developments
Table 122. Rentschler Biopharma Details, Company Type, CMO and CDMO biotechnology Area Served and Its Competitors
Table 123. Rentschler Biopharma CMO and CDMO biotechnology Product Offered
Table 124. Rentschler Biopharma Main Business
Table 125. Rentschler Biopharma CMO and CDMO biotechnology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Rentschler Biopharma Latest Developments
LIST OF FIGURES
Figure 1. CMO and CDMO biotechnology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CMO and CDMO biotechnology Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. CMO and CDMO biotechnology Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. CMO and CDMO biotechnology Sales Market Share by Country/Region (2022)
Figure 8. CMO and CDMO biotechnology Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global CMO and CDMO biotechnology Market Size Market Share by Type in 2022
Figure 10. CMO and CDMO biotechnology in Large Enterprise
Figure 11. Global CMO and CDMO biotechnology Market: Large Enterprise (2018-2023) & ($ Millions)
Figure 12. CMO and CDMO biotechnology in SME
Figure 13. Global CMO and CDMO biotechnology Market: SME (2018-2023) & ($ Millions)
Figure 14. Global CMO and CDMO biotechnology Market Size Market Share by Application in 2022
Figure 15. Global CMO and CDMO biotechnology Revenue Market Share by Player in 2022
Figure 16. Global CMO and CDMO biotechnology Market Size Market Share by Regions (2018-2023)
Figure 17. Americas CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 18. APAC CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 19. Europe CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 21. Americas CMO and CDMO biotechnology Value Market Share by Country in 2022
Figure 22. United States CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC CMO and CDMO biotechnology Market Size Market Share by Region in 2022
Figure 27. APAC CMO and CDMO biotechnology Market Size Market Share by Type in 2022
Figure 28. APAC CMO and CDMO biotechnology Market Size Market Share by Application in 2022
Figure 29. China CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 33. India CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe CMO and CDMO biotechnology Market Size Market Share by Country in 2022
Figure 36. Europe CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Figure 37. Europe CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Figure 38. Germany CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 39. France CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Figure 46. Egypt CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 52. APAC CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 53. Europe CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 55. United States CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 56. Canada CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 57. Mexico CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 58. Brazil CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 59. China CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 60. Japan CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 61. Korea CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 63. India CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 64. Australia CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 65. Germany CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 66. France CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 67. UK CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 68. Italy CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 69. Russia CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 70. Spain CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 71. Egypt CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 72. South Africa CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 73. Israel CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 74. Turkey CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 76. Global CMO and CDMO biotechnology Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global CMO and CDMO biotechnology Market Size Market Share Forecast by Application (2024-2029)
Figure 1. CMO and CDMO biotechnology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CMO and CDMO biotechnology Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. CMO and CDMO biotechnology Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. CMO and CDMO biotechnology Sales Market Share by Country/Region (2022)
Figure 8. CMO and CDMO biotechnology Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global CMO and CDMO biotechnology Market Size Market Share by Type in 2022
Figure 10. CMO and CDMO biotechnology in Large Enterprise
Figure 11. Global CMO and CDMO biotechnology Market: Large Enterprise (2018-2023) & ($ Millions)
Figure 12. CMO and CDMO biotechnology in SME
Figure 13. Global CMO and CDMO biotechnology Market: SME (2018-2023) & ($ Millions)
Figure 14. Global CMO and CDMO biotechnology Market Size Market Share by Application in 2022
Figure 15. Global CMO and CDMO biotechnology Revenue Market Share by Player in 2022
Figure 16. Global CMO and CDMO biotechnology Market Size Market Share by Regions (2018-2023)
Figure 17. Americas CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 18. APAC CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 19. Europe CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa CMO and CDMO biotechnology Market Size 2018-2023 ($ Millions)
Figure 21. Americas CMO and CDMO biotechnology Value Market Share by Country in 2022
Figure 22. United States CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC CMO and CDMO biotechnology Market Size Market Share by Region in 2022
Figure 27. APAC CMO and CDMO biotechnology Market Size Market Share by Type in 2022
Figure 28. APAC CMO and CDMO biotechnology Market Size Market Share by Application in 2022
Figure 29. China CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 33. India CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe CMO and CDMO biotechnology Market Size Market Share by Country in 2022
Figure 36. Europe CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Figure 37. Europe CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Figure 38. Germany CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 39. France CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa CMO and CDMO biotechnology Market Size Market Share by Application (2018-2023)
Figure 46. Egypt CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country CMO and CDMO biotechnology Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 52. APAC CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 53. Europe CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 55. United States CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 56. Canada CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 57. Mexico CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 58. Brazil CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 59. China CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 60. Japan CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 61. Korea CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 63. India CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 64. Australia CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 65. Germany CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 66. France CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 67. UK CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 68. Italy CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 69. Russia CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 70. Spain CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 71. Egypt CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 72. South Africa CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 73. Israel CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 74. Turkey CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries CMO and CDMO biotechnology Market Size 2024-2029 ($ Millions)
Figure 76. Global CMO and CDMO biotechnology Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global CMO and CDMO biotechnology Market Size Market Share Forecast by Application (2024-2029)
